← Leaderboards
Christine E Koval
University Of Rochester
$563,490
Attributed
$563,490
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $125.1K · FY2005–06$200K$150K$100K$50K$0
'05
'06
Funding mix
By agency
NIH$563,490 · 1
By mechanism
K08$563,490 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Rochester
Same institution · by research overlap
- Baek Kim$21,816,663
- Stephen Dewhurst$37,837,871
- Mahin D. Maines$9,697,031
- Ann R Falsey$14,447,817
- Joshua C Munger$7,689,220
Others in their field
Top investigators on “Site Directed Mutagenesis”
- Constance Ann Benson · University Of California, San Diego$65,790,143
- Richard J Ulevitch · Scripps Research Institute$27,055,189
- Myron Fredric Goodman · University Of Southern California$18,982,784
- Pieter J. De Jong · Children'S Hospital &Res Ctr At Oakland$18,178,966
- Richard C. Mohs · Mount Sinai School Of Medicine Of Nyu$17,686,819
- Keith W Miller · Massachusetts General Hospital$16,440,674
Research focus
Site Directed MutagenesisRna Directed Dna PolymeraseEfavirenzEnzyme ActivityGene MutationGenetic StrainHiv InfectionsHuman Immunodeficiency Virus 1Human TissueClinical ResearchVirus ReplicationDrug Resistance
Grant awards (5)
Impact of efavirenz resistance mutations on HIV-1$84,618
K08 · FY2006 · AI · contact PI
Impact of efavirenz resistance mutations on HIV-1$125,118
K08 · FY2005 · AI
Impact of efavirenz resistance mutations on HIV-1$125,118
K08 · FY2004 · AI
Impact of efavirenz resistance mutations on HIV-1$114,318
K08 · FY2003 · AI
Impact of efavirenz resistance mutations on HIV-1$114,318
K08 · FY2002 · AI